Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FQJW8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,279
Award facts
- Contract value 100% obligated
- $26,279.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $26,279.04 to DMS Pharmaceutical Group Inc. for 52 milligram Mirena systems on January 28, 2026, with a completion date of February 19, 2026. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating competitive capability in unrestricted federal procurement. The delivery order is issued under the company's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499.999 billion ceiling value through December 31, 2036.
The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors supplying pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's contract is structured as a 30-month base period with three 30-month option periods, authorizing the Defense Logistics Agency to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and specialty pharmaceuticals. The Mirena contraceptive system delivery order reflects the company's established role as a critical pharmaceutical supplier supporting military healthcare operations globally, with no subcontractors identified in the award documentation.
Quick answers
Who was awarded contract SPE2DR26FQJW8?
SPE2DR26FQJW8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FQJW8 worth?
The government has obligated $26,279 on SPE2DR26FQJW8.
Is contract SPE2DR26FQJW8 an order under another contract?
Yes. SPE2DR26FQJW8 is a delivery order under SPE2DR25D9135, an indefinite delivery contract.
Was contract SPE2DR26FQJW8 competed?
The extent of competition for SPE2DR26FQJW8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award